Status: Recruiting
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency
STUDY OBJECTIVE To assess if acoltremon 0.003% improves tear production in patients with Stage 1 Neurotrophic Keratopathy.
Participants needed: 50
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University of South FloridaUpdated: Mar 31, 2026Locations: 1
Eligibility criteria
Neurotrophic Keratopathy stage 1 diagnosis based on the following: Presence of 3... [+3]
Evidence of any active ocular infection or any intraocular inflammation. [+10]